Literature DB >> 27449854

Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.

Michael C Levin1, Sangmin Lee2, Lidia A Gardner2, Yoojin Shin2, Joshua N Douglas3, Hannah Salapa3.   

Abstract

Several years following its discovery in 1980, infection with human T-lymphotropic virus type 1 (HTLV-1) was shown to cause HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease biologically similar to progressive forms of multiple sclerosis (MS). In this manuscript, we review some of the clinical, pathological, and immunological similarities between HAM/TSP and MS with an emphasis on how autoantibodies to an RNA binding protein, heterogeneous nuclear ribonuclear protein A1 (hnRNP A1), might contribute to neurodegeneration in immune mediated diseases of the central nervous system. Published by Elsevier B.V.

Entities:  

Keywords:  Autoimmunity; HTLV-1; Multiple sclerosis; Neurodegeneration; RNA; RNA binding protein

Mesh:

Substances:

Year:  2016        PMID: 27449854     DOI: 10.1016/j.jneuroim.2016.07.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms.

Authors:  Yanjun Ding; Taotao Li; Xinwei Yan; Mintian Cui; Chao Wang; Situo Wang; Fengmin Zhang; Ruijie Zhang
Journal:  Mol Genet Genomics       Date:  2021-01-28       Impact factor: 3.291

2.  Profiling of IgG antibodies targeting unmodified and corresponding citrullinated autoantigens in a multicenter national cohort of early arthritis in Germany.

Authors:  Stefan Vordenbäumen; Ralph Brinks; Patrick Schriek; Angelika Lueking; Jutta G Richter; Petra Budde; Peter Schulz-Knappe; Hans-Dieter Zucht; Johanna Callhoff; Matthias Schneider
Journal:  Arthritis Res Ther       Date:  2020-07-06       Impact factor: 5.156

Review 3.  The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models.

Authors:  Cole D Libner; Hannah E Salapa; Michael C Levin
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

4.  Monoclonal antibody against H1N1 influenza virus hemagglutinin cross reacts with hnRNPA1 and hnRNPA2/B1.

Authors:  Chunyan Guo; Lijun Sun; Shuangping Hao; Xiaoyan Huang; Hanyu Hu; Daoyan Liang; Qing Feng; Yan Li; Yangmeng Feng; Xin Xie; Jun Hu
Journal:  Mol Med Rep       Date:  2020-09-07       Impact factor: 2.952

5.  Monoclonal Antibody Targeting the HA191/199 Region of H1N1 Influenza Virus Mediates the Damage of Neural Cells.

Authors:  Chun-Yan Guo; Qing Feng; Li-Ting Yan; Xin Xie; Dao-Yan Liang; Yan Li; Yang-Meng Feng; Li-Jun Sun; Jun Hu
Journal:  Biochemistry (Mosc)       Date:  2021-11       Impact factor: 2.487

6.  ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses.

Authors:  Anna-Maria Herzner; Zia Khan; Eric L Van Nostrand; Sara Chan; Trinna Cuellar; Ronald Chen; Ximo Pechuan-Jorge; Laszlo Komuves; Margaret Solon; Zora Modrusan; Benjamin Haley; Gene W Yeo; Timothy W Behrens; Matthew L Albert
Journal:  J Exp Med       Date:  2021-07-23       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.